Forecasting Hepatitis C liver disease burden on real‐life data. Does the <i>hidden iceberg</i> matter to reach the elimination goals?Loreta A. Kondili, Francesco Paolo Russo, Teresa Santantonio et al.|Liver International|2018Cited by 45
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosisAntonio Ascione, N. Caporaso, M. De Luca et al.|Infection|2018Cited by 8
HCV–Related Mixed Cryoglobulinemia: Data from Piter, a Nationwide Italian HCV Cohort StudyLoreta A. Kondili, Salvatore Petta, Weimer LE et al.|Journal of Hepatology|2016Cited by 5
HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort studyLiliana Elena Weimer, O. Patti, M. Vinci et al.|Digestive and Liver Disease|2016Cited by 1
Multifactor risk evaluation in patients who have eradicated HCV infection: an interim analysis in the PITER cohortLoreta A. Kondili, Vincenza Calvaruso, Mg Quaranta et al.|Journal of Hepatology|2018Cited by 0